Trials / Completed
CompletedNCT03451721
Observation of ImageReady™ MR Conditional Defibrillation System in China
Observation of ImageReady™ MR Conditional Defibrillation System in China (MR ICD)
- Status
- Completed
- Phase
- N/A
- Study type
- Interventional
- Enrollment
- 20 (actual)
- Sponsor
- Boston Scientific Corporation · Industry
- Sex
- All
- Age
- 18 Years
- Healthy volunteers
- Not accepted
Summary
To observe the safety and effectiveness of ImageReady™ MR conditional defibrillation system in a Chinese population.
Detailed description
This is a multi-center, prospective, single-arm study, aimed to observe the safety and effectiveness of ImageReady™ MR conditional defibrillation system in a Chinese population.It will enroll 20 subjects in 5 sites in China.The primary safety endpoint is MR scan-related Complication-free rate between the MR Scan and the MRI + 1 Month Visit. The primary effectiveness endpoints include:1.Abnormal increase in RV shocking impedance from the pre-MR scan to the 1 Month post-MR scan. 2.Increase in RV pacing threshold from the pre-MR scan to the 1 Month post-MR scan. 3.Decrease in RV sensed amplitude from the pre-MR scan to the 1 Month post-MR scan. 4.Increase in LV pacing threshold from the pre-MR scan to the 1 Month post-MR scan. 5.Decrease in LV sensed amplitude from the pre-MR scan to the 1 Month post- MR scan.
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| DEVICE | ImageReady™ MR Conditional Defibrillation System | Subject will receive an ICD or CRT-D pulse generator in the left or right pectoral region ICD |
Timeline
- Start date
- 2018-04-03
- Primary completion
- 2019-03-12
- Completion
- 2019-12-10
- First posted
- 2018-03-02
- Last updated
- 2021-11-01
- Results posted
- 2020-04-24
Locations
1 site across 1 country: China
Source: ClinicalTrials.gov record NCT03451721. Inclusion in this directory is not an endorsement.